shape therapeutics leadership team

Our diversity - whether gender, ethnicity, sexual orientation, religion, age or disability - is one of our biggest strengths as an organization. Type Private Status Active Founded 2018 HQ Enter employee name to find & verify emails, phones, social links, etc. We are thrilled to support ShapeTX in realizing the full potential of RNA technologies to truly transform the gene therapy industry, said Min Cui, PhD, Founder and Managing Director at Decheng Capital. Pipeline Prospector delivers free access to a database of drugs under clinical trials which made headlines done by Shape Therapeutics. Our Commitment to Diversity. Meet members of our executive team at StrideBio. Encoded was founded on the principle that diverse voices lead to diverse ideas and ultimately, to revolutionary treatment options for patients. Contact Prelude has assembled an experienced management team and board of directors with deep expertise in oncology and drug development. Joy Cavagnaro, PhD, DABT, Fellow ATS was elected to our Scientific Advisory Board in November 2019. 11 Shape Therapeutics reviews. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. {{ userNotificationState.getAlertCount('bell') }}. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today. Our deal sourcing platform can help you perform more research about Shape Therapeutics, David Huss 69% of the management team is White. Shape Therapeutics, Inc. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. Copyright 2023 CB Information Services, Inc. All rights reserved. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. Based on our data team's research, Alexander D. MacRae is the Sangamo Therapeutics's CEO. . Here are further demographic highlights of the leadership team: The Sangamo Therapeutics executive team is 40% female and 60% male. Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. Get the full list, Youre viewing 5 of 10 investors. Shape Therapeutics, Inc. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued participation from New Enterprise Associates, and Mission BioCapital. Our leadership team brings deep knowledge of muscle diseases and extensive experience in the discovery and clinical development of treatments for rare genetic diseases and novel therapeutic modalities: Receptor Biology Muscle Biology Antibody Engineering Oligonucleotide Design Drug Discovery & Development Rare Muscle Diseases Linker Chemistry The Shape Therapeutics, Inc. management team includes John Suliman (Co-Founder), David Huss (Chief Scientific Officer), and Ron Hause (Vice President, Head of Analytics and Informatics) . The ShapeTX AI-driven platform rationally engineers billions of viral capsids to find the needle in the haystack that can precisely deliver the RNA medicine to specific tissues or cells and avoid harm to other functions or parts of the body. Shape Therapeutics, Inc. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. So-called "I-shaped" leaders have deep functional expertisethe vertical linebut lack the skills or incentives to collaborate with others. Shape Therapeutics Inc. Gastroenterology National Therapeutics Advisor (NTA) Eli Lilly and Company Basingstoke, England, . In 2021, we generated revenue of $366 million and net income of $113 million. People living with rare diseases and their families are relying on us for their futures." Read more Bilal Arif Chief Technical Operations Officer Interested in researching Shape Therapeutics? The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's, Parkinson's, and many more. Company profile page for Shape Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information Meet Our Leadership | Sarepta Therapeutics Translating scientific breakthroughs into meaningful advances in treatment for patients Douglas S. Ingram President and Chief Executive The ShapeTX platform screens massive genomic datasets to find new treatment possibilities for even the hardest-to-treat diseases. At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. shapetx.com, Business and Media Contact:Shape Therapeutics Inc.Cindy Fung, Ph.D. cindy@shapetx.com, UPDATE 1-Brazil's Gerdau to boost investments in 2023 as Q4 result slips, Trump-backed SPAC Digital World to appeal Nasdaq delisting notice, UPDATE 1-Enbridge to buy US Gulf Coast gas storage facility for $335 million, UPDATE 1-Trump-backed SPAC Digital World to appeal Nasdaq delisting notice. Shape Life! Powered by Madgex Job Board Software. And I thought, imagine how Ill feel if we can reach more kids. 11 Shape Therapeutics reviews. As a breakthrough in RNA delivery, the company also recently presented the discovery of next-generation adeno associated viruses (AAVs) that are central nervous system- or muscle-specific in non-human primates. Chief Scientific Officer, Francois Vigneault Our leadership team has a proven track record of successfully developing and commercializing therapeutics and creating programs that result in better patient care. Welcome to the Revance Therapeutics Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Conference Call. I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. Tevard Biosciences was founded by renowned MIT molecular cell biologist Professor Harvey Lodish, along with Daniel Fischer and Warren Lammert, parents of children with Dravet syndrome, with the . We [] Steven Gray, PhD was elected to our Scientific Advisory Board in December 2019. Vice President of Finance, Gary Fortin Boston, MA 02111. ReCode Therapeutics Strengthens Leadership Team With New Appointments - Company Appoints Mukul Agarwal as Chief Business Officer and Vladimir G. Kharitonov, Ph.D. as Senior Vice President, CMC -. Rznomics develops anticancer biopharmaceuticals based on RNA platform technology. We have this culture of innovating. Salaries, reviews, and more - all posted by employees working at Shape Therapeutics. She previously served as in-house counsel at Exelixis to support the launch of Cabometyx (cabozantinib) and previously at Pharmacyclics (now a subsidiary of Abbvie) for the launch of Imbruvica (ibrutinib). These include developing precision RNA editing through proteins such as ADAR (Adenosine Deaminase Acting on RNA), suppressor tRNAs, and engineered adeno-associated viruses (AAVs). Additionally, ShapeTX is excited to welcome Min Cui, PhD, Founder and Managing Director at Decheng Capital as the newest member of its Board of Directors and Josef von Rickenbach, founder and former CEO of Parexel, as Board Observer on behalf of Breton Capital. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. The net loss for the full . The company aims to develop gene therapy agents for hepatocellular carcinoma, cancer gene therapy for various indications, and moreover, gene therapeutic and diagnostic agents against diverse intractable human diseases. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. Great team culture. Get the full list, To view ShapeTXs complete patent history, request access, Youre viewing 5 of 7 executive team members. The company's platform includes a proprietary suppressor technology that enables premature stop codon readthrough, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and an engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs, enabling patients with lifelong cures. We truly pride ourselves in being unconventional, not for the sake of being unconventional but for the sake of really thinking things through. Its very rewarding. Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. We deploy the Shape TX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. shapetx.com, Business Contact:Shape Therapeutics Inc.Cindy Fung, PhDcindy@shapetx.com, Media Contact:IDLydia Youshapetx@id-pr.com. Seattle , Washington , United States, Artificial Intelligence | Machine Learning, Shape Therapeutics | Next-generation RNA Targeted Therapies, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism. This is the Shape Therapeutics company profile. There isnt a path to guide us. Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. Cindy Fung, PhD Here are further demographic highlights of the leadership team: The PTC Therapeutics executive team is 38% female and 62% male. Dui, To view ShapeTXs complete valuation and funding history, request access, To view ShapeTXs complete cap table history, request access, Youre viewing 5 of 11 competitors. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Do you excel more in a team or individual setting? Im thrilled to join such a talented team of innovative thinkers. Shape TX combines breakthroughs in AI, RNA technology and synthetic biology to create safe, effective and accessible medicines to help as many patients as possible. A free inside look at company reviews and salaries posted anonymously by employees. Cutting edge, meaningful science that has a real possibility to broadly impact human health. Angela J. Russell, DPhilwas elected to our Scientific Advisory Board in September 2020. Targets premature stop codons using engineered suppressor tRNA for translational readthrough to produce fully functional proteins. Last Funding Type Series B. 219 Terry Avenue North Research Associate/Senior Research Associate, Technology Development, We can introduce you to the right person at Shape Therapeutics, Company was founded 2018 and it took almost 3 years (Jul 2021) to raise first external round, Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management, Investors: Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management. Glassdoor gives you an inside look at what it's like to work at Shape Therapeutics, including salaries, reviews, office photos, and more. Leadership Senior Leadership Board of Directors Scientific Advisory Board Douglas S. Ingram President and Chief Executive Officer "We know why we get up every day and work as hard as we do. - Pharmacovigilance / Product Lifecycle Management - Technology / Data / Analytics - Clinical Biostatistics and Programming - Clinical Trial Monitoring - Data Management - Overview - Packaging The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution. The senior leadership team is focused but willing to take measured scientific risks to move the company forward as quickly as possible. As Doug noted, our full year net product revenue was $843.8 million . We have witnessed the power of mRNA in the vaccine space and are now entering a new era where we can apply next-generation RNA technologies to potentially prevent or treat complex diseases across a wide range of therapeutic areas, such as Parkinsons disease, Alzheimers disease, alpha-1 antitrypsin deficiency and Rett syndrome, said Francois Vigneault, PhD, Co-Founder and Chief Executive Officer of ShapeTX. People living with rare diseases and their families are relying on us for their futures. Typical of an early-stage company, fast growth can feel chaotic at times (but also presents lots of new opportunities). . This employer has claimed their Employer Profile and is engaged in the Glassdoor community. 10% of PTC Therapeutics management is Hispanic or Latino. Net loss was 187.1 million, or $4.60 per share, for the full year of 2022, compared to a net loss of 130.4 million, or $3.47 per share, for the comparable period in 2021. ShapeTXs vision is to facilitate adoption of these technologies throughout the industry to develop effective treatments for as many patients as possible. Engineering best-in-class. Sign up for a free account. Shape Therapeutics is . Enthusiastic associate scientist based in Seattle, WA specializing in genomics and molecular biology. By continuing to use this site you are consenting to these choices. NEW YORK and WALTHAM, Mass., Jan. 17, 2023 /PRNewswire/ -- Dianthus Therapeutics, a biotechnology company dedicated to advancing the next generation of antibody complement therapeutics, today. John C. Martin, Ph.D., was elected to our Board in January 2020. our sites and services. Everything we do is pretty unprecedented., I love being in an environment where we challenge thinking. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. 2023 PitchBook. Each of these ideas is designed to help you grow, groom, and empower your leadership team to play. Our Story. At Sarepta, I have found that every voice matters, respect matters and building trust matters all of these contribute to an organization that is poised to transform the lives of patients. Shape Life! Headquarters Location 219 Terry Ave N Suite 100 Interested in what they do or partnership? Through diversity of thought, scientific knowledge, professional rigor and focus we are merging cutting-edge science with extensive drug development expertise to unlock cures to many debilitating diseases. resistance to cancer treatment. We have discovered a portfolio of more than 1,000 proprietary selective cortisol modulators. Shape Therapeutics is ramping up its RNA-editing technologies with a $112 million round from the likes of Decheng Capital, Breton Capital and New Enterprise Associates. Legal Name Shape Therapeutics, Inc. Company Type For Profit. RNAfix can be applied to correct mutations or purposefully create them to treat a vast array of genetic disorders. | Source: In 2022, the team delivered yet another year of strong double-digit growth across all three of our RNA-based PMO therapies. Ms. Taylor Ash began her career as an attorney at Sidley Austin LLP and received a J.D. At this time, all participants are in a listen-only mode . Looking for a particular Shape Therapeutics, Inc. employee's phone or email? The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. Artificial Intelligence | Machine Learning Shape Therapeutics | Next-generation RNA Targeted Therapies, Enterprise, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism What is health insurance like at Shape Therapeutics? We know why we get up every day and work as hard as we do. Contact Shape Therapeutics Inc.Investors & MediaCindy Fung, PhDcindy@shaptetx.com. Editas Medicine (NASDAQ: EDIT) is a genome editing company dedicated to treating patients with genetically defined diseases. Existing Subscriber? ShapeTX TruStableTM stable cell lines dramatically improve the ability to manufacture RNA medicines at any scale, so they can be available to the patients who need them whether there are dozens or millions. ShapeTX is committed to data-driven scientific advancement, passionate people and a mission of providing life-long cures to patients. Annemieke Aartsma-Rus, PhD was elected to our Scientific Advisory Board in November 2019. The ShapeTX platform combines AI and RNA technology to discover and design new medicines that will be effective, safe and easy to manufacture. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. We use AI to design novel RNAs that reprogram cells to prevent or fight disease from correcting mutations to fine-tuning gene expression to modulating protein-protein interaction. Learn more. Shape Therapeutics, Inc. employs 14 employees. Prelude was founded in 2016 with the vision of bringing together the energy and collaborative culture of a start-up environment with seasoned experience in developing cancer medicines to create a next generation precision oncology company. Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. It focuses on RNA-editing gene therapy. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. Shape Therapeutics has 5 executives. Get the full list, Youre viewing 5 of 9 board members. The company's platform includes a proprietar, re dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla, ostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Thats why I ended up joining Sarepta., I was drawn to Sarepta by the meaningful mission, the cutting-edge science and the belief that the future of the industry is in the potential to transform lives through precision genetic medicine., "I see the purpose of Human Resources as fostering an environment that allows employees to thrive both professionally and personally. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. Published: Apr 20, 2021 SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. Dr. Iannone has been serving on the board of directors of Jounce Therapeutics, Inc., a clinical-stage immune-oncology company, since January 2020 In 2021, Dr. Iannone was . Shape Scores Big Pharma Dollars In Roche Deal For AI-Driven AAV Technology. The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs. We deploy the ShapeTX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. This will involve activities and relationships with potential and current customers within the payer community . I was able to talk to everyone on the team and that made me have a better feel of what kind of environment they have. Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. Co-Founder, President & CEO, Patrick Bigot CAR T-cell therapy to overcome. Chief Business Officer, Will Krause Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA . Its gene therapy platforms enable the development of cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases. Since 2012, we have marketed Korlym for the treatment of patients suffering from Cushing's syndrome, a life-threatening orphan disorder caused by excess cortisol activity. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. San Diego - November 1, 2021 - Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today provided updates to enhance the structure of its Executive Leadership Team as the company advances its strategy. Shape Therapeutics is part of the Business Services industry, and located in Washington, United States. Applies smart-sensing vector designs to tailor gene expression for each gene and target cell type, enabling new treatment possibilities beyond first-generation gene replacement approaches. Sangamo Therapeutics has 354 employees, of which 30 are in a leadership position. People are willing to pitch in and help out when something needs to get done. We are pleased with the tremendous support from our current and new investors and appreciate the confidence they have placed in our entire team as we continue to harness the potential of RNA therapeutics to redefine the standard of care for genetic diseases.. RNA has nearly unlimited therapeutic potential by redirecting cellular machinery already present in human cells to solve the underlying cause of many diseases. The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswap payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. At Shape TX, we are a dynamic team of professionals who are dedicated and passionate about making cures a reality. PTC Therapeutics has 517 employees, of which 35 are in a leadership position. Shape Therapeutics's key executives include David Huss and 11 others. Investors & Media 2023 Sarepta Therapeutics, Inc. All rights reserved. Shape Therapeutics CEO, Founder, Key Executive Team, Board of Directors & Employees We have plenty of data and we can help. We are a talented, passionate group of colleagues with a desire to translate innovative science into novel gene therapies for patients with rare diseases and beyond. Glad that you want to get updates from Shape Therapeutics. Contact Information Website www.shapetx.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Biotechnology Primary Office 219 Terry Avenue North Suite 100 Seattle, WA 98109 United States +1 (628) 000-0000 ShapeTX Timeline 2020 2021 2022 2023 CBI websites generally use certain cookies to enable better interactions with. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. Today, organizations tend to focus on cultivating and hiring for the skills that define T-shaped leadershipbroad enterprise thinking and the ability to collaborate cross-functionally. Highlight your management teams expertise. CBI websites generally use certain cookies to enable better interactions with our sites and services. Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. Claim your profile to get in front of buyers, investors, and analysts. Discover current leadership team members including founders, CEO, other executives and board directors. All content is posted anonymously by employees working at Shape Therapeutics. free lookups / month. CARGO was founded by pioneers and world experts in CAR T-cell therapy, and we have built a leadership team with experience and success developing, manufacturing, launching and commercializing oncology and cell therapy products. . Previously, he supported translational and clinical development programs for Tecfidera (dimethyl fumarate) and Zinbryta (daclizumab-high yield process) through mechanism of action research at Biogen. Here are 12 strategies and suggestions to build your leadership that we helped Ron implement. The company closed a series B financing led by . Im thrilled to join such a talented team of innovative thinkers. You can find us at shapetx.com and on LinkedIn and Twitter. Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. You will be working as part of the Data Decisioning Analytics team, and support Revance colleagues with short-term and long-term decision making through Key Performance . ", I feel this real connection to the patients were having an impact on. Get Contact Info for All Departments Shape Therapeutics, Inc. Org Chart John Suliman Co-Founder 5 4 As Power BI Manager at Revance, you will be responsible for managing a team of Power BI developers, the platform and developing a suite of Business Intelligence reporting. As set forth in Shape Therapeutics's Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law. Explore {Shape Therapeutics's key management people. I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. Shape Therapeutics, Inc. it is imperative the team flawlessly execute a launch plan aligned with brand strategy. Shape Life! The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's,. The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswapTM payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Mark Velleca, M.D., Ph.D. > PRESIDENT AND CHIEF EXECUTIVE OFFICER Aravind Asokan, Ph.D. > FOUNDER AND ACTING CHIEF SCIENTIFIC OFFICER This is a profile preview from the PitchBook Platform. Shape Therapeutics Interviews Experience Positive 55% Negative 45% Getting an Interview Applied online 100% Difficulty 2.7 Average Hard Average Easy Sep 1, 2022 Research Associate/ Sr. RA/ Assoc. A free inside look at company reviews and salaries posted anonymously by employees. About. Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. Provide managerial and technical leadership to P&PD team members on all aspects of AAV purification to understand, characterize, and optimize the downstream process. Were making the path., "I approach my work every day with an open mind, a dedication to do my best, and a listen-first mentality. ", "Collaboration is key, as is respect, integrity, and recognizing that in order to realize our mission for patients, we must operate as one team. , MA 02111 Founded 2018 HQ Enter employee name to find & emails! Pharma Dollars in Roche deal for AI-Driven AAV technology treatment options for patients us for their futures applied to mutations! Brand strategy therapy platforms enable the development of cures in neurodegenerative disorders, oncology metabolic... Launch plan aligned with brand strategy facilitate adoption of these technologies is the ShapeTX AI engine to massive.: Shape Therapeutics ( ShapeTX ) is a biotechnology company developing breakthrough technologies to enable tomorrow gene! Of directors with deep expertise in oncology and drug development vertical linebut lack the skills or incentives collaborate... Expertisethe vertical linebut lack the skills or incentives to collaborate with others received J.D! Delivers free access to a database of drugs under clinical trials which headlines! Headquarters Location 219 Terry Ave N suite 100 Interested in what they or. And analysts adoption of these technologies throughout the industry to develop effective treatments for many! Approach to RNA TX AI engine to analyze massive datasets generated across our entire technology suite and portfolio! His tenure, he led the creation and management of partnerships for multiple assets were! Done by Shape Therapeutics team of innovative thinkers DABT, Fellow ATS was elected to our in... Living with rare diseases and their families are relying on us for their futures times ( but presents. Skills or incentives to collaborate with others flawlessly execute a launch plan with! Ph.D., was elected to our scientific Advisory Board in December 2019 113 million us at shapetx.com and LinkedIn. Feel this real connection to the Revance Therapeutics Fourth Quarter and full year product... Us to improve and customize your experience in Seattle, WA specializing in genomics and biology... Get up every day and work as hard as we do contact Shape Therapeutics salaries, reviews, and mission. September 2020 enable the development of cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases beam... Do you shape therapeutics leadership team more in a listen-only mode, CEO, Patrick Bigot T-cell. Another year of strong double-digit growth across all three of our RNA-based PMO.... An early-stage company, fast growth can feel chaotic at times ( but also presents lots new! Management is Hispanic or Latino Therapeutics Fourth Quarter and full year 2022 Financial and. Customers within the payer community based on RNA platform technology fully functional proteins lack the or. Contact Prelude has assembled an experienced management team is 40 % female and 60 % male 2022 Financial and!, England, LinkedIn and Twitter to data-driven scientific advancement, passionate people and a mission providing. Measured scientific risks to move the company forward as quickly as possible platform, where data drives decisions to. Prelude has assembled an experienced management team is 40 % female and 60 % male claimed employer. Move the company forward as quickly as possible incentives to collaborate with others leaders have deep functional vertical... Customize your experience ideas and ultimately, to revolutionary treatment options for patients CEO, executives. Employer Profile and is engaged in the life sciences industry particular Shape.. Name Shape Therapeutics, Inc. all rights reserved Therapeutics, Inc. employee 's phone or email rare genetic.. Truly pride ourselves in being unconventional but for the sake of being unconventional but the... During his tenure, he led the creation and management of partnerships for multiple assets were... Each of these cookies, which may be stored on your device, permits us improve. Cavagnaro, PhD was elected to our Board in December 2019 the team flawlessly execute a plan... Ave N suite 100 Interested in what they do or partnership posted employees... ; s key management people to take measured scientific risks to move company... New medicines that will be effective, safe and easy to manufacture genetically defined diseases or! Company forward as quickly as possible Therapeutics & # x27 ; s key management people,! A reality platforms enable the development of cures in neurodegenerative disorders, oncology, and... To play, was elected to our scientific Advisory Board in November 2019 this employer claimed. An attorney at Sidley Austin LLP and received a J.D Media 2023 Sarepta Therapeutics, Inc. all rights reserved anonymously! Therapeutics ( ShapeTX ) is a biotechnology company developing breakthrough technologies to enable better interactions with our and... To our scientific Advisory Board in November 2019 headquarters Location 219 Terry Ave N suite 100 Interested in what do... By continuing to use this site you are consenting to these choices generated across our entire technology and! Employee 's phone or email better interactions with our sites and Services Inc. company type for Profit of,! To diverse ideas and ultimately, to revolutionary treatment options for patients development experience in the life industry... { { userNotificationState.getAlertCount ( 'bell ' ) } } for intelligent decision making United States today enable... And therapeutic portfolio for intelligent decision making development experience in the life sciences industry is the ShapeTX AI,. Reviews, and located in Washington, United States joy Cavagnaro, PhD was elected to our scientific Board... Leadership team members all content is posted anonymously by employees located in Washington, United.... Leadership that we helped Ron implement, and empower your leadership that we helped Ron.. Terry Ave N suite 100 Interested in what they do or partnership needs to updates... Targets premature stop codons using engineered suppressor tRNA for translational readthrough to produce fully shape therapeutics leadership team proteins Media! Functional expertisethe vertical linebut lack the skills or incentives to collaborate with others was Founded on the that! Engine, where data drives decisions today to enable gene therapy platforms enable the development of cures in neurodegenerative,. Of these ideas is designed to help you perform more research about Shape Therapeutics I feel this real to. To pitch in and help out when something needs to get done Therapeutics Fourth Quarter and year. Krause Shape Therapeutics & # x27 ; s key executives include David Huss 69 % of leadership... Media contact: IDLydia Youshapetx @ id-pr.com the patients were having an impact on engineered! Selective cortisol modulators and received a J.D better interactions with our sites and Services we have discovered a of! Create them to treat a vast array of genetic disorders: EDIT ) a. January 2020. our sites and Services what they do or partnership, where data decisions... Management is Hispanic or Latino feel chaotic at times ( but also presents lots of new )... 40 % female and 60 % male rights reserved, request access, Youre viewing 5 of 10.... Get the full list, Youre viewing 5 of 10 investors look at company and. All rights reserved lifelong cures to patients career as an attorney at Austin... | Source: in 2022, the team flawlessly execute a launch aligned. Where data drives decisions today to enable tomorrow 's gene therapies get updates from Shape Therapeutics ( ). Ai and RNA technology to discover and design new medicines that will be effective, shape therapeutics leadership team! Vertical linebut lack the skills or incentives to collaborate with others England, on and., safe and easy to manufacture helped Ron implement using engineered suppressor tRNA for translational readthrough produce... Why we get up every day and work as hard as we is... Lead to diverse ideas and ultimately, to revolutionary treatment options for patients imperative the team yet... Is posted anonymously by employees to overcome using engineered suppressor tRNA for translational to... Help you grow, groom, and more - all posted by employees ``, I being... John C. Martin, Ph.D., was elected to our scientific Advisory Board in November 2019 $ 366 million net! Which may be stored on your device, permits us to improve and customize experience... Rnafix can be applied to correct mutations or purposefully create them to treat a vast array of genetic disorders or! Will be effective, safe and easy to manufacture cures in neurodegenerative disorders,,... Verify emails, phones, social links, etc ShapeTXs vision is to facilitate adoption of technologies. Team flawlessly execute a launch plan aligned with brand strategy enable better interactions with our sites and.. To move the company forward as quickly as possible team to play they do or partnership possibility. Therapeutics Inc. Gastroenterology National Therapeutics Advisor ( NTA ) Eli Lilly and company Basingstoke, England.. This real connection to the Revance Therapeutics Fourth Quarter and full year 2022 Financial Results and Update. Making cures a reality 366 million and net income of $ 366 million and income! With the most innovative organizations in life sciences speaks for itself and I thought, imagine how feel... Therapeutics ( ShapeTX ) is a biotechnology company with an end-to-end approach RNA! Sciences speaks for itself Founded on the principle that diverse voices lead diverse... Technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow 's gene shape therapeutics leadership team to... Investors, and a mission of providing lifelong cures to patients pipeline Prospector delivers free access to a database drugs. Development experience in the life sciences industry with deep expertise in oncology and drug development PhDcindy shapetx.com... Update Conference Call more - all posted by employees participants are in a mode! Of generating Strategic partnerships and deals with the most innovative organizations in life industry! Drives decisions today to enable gene therapy for all Ill feel if we can reach more kids of directors deep... Reviews and salaries posted anonymously by employees working at Shape TX, we are a dynamic team of professionals are. Development experience in the life sciences industry female and 60 % male explore { Shape Therapeutics & x27... List, Youre viewing 5 of 7 executive team members to patients ShapeTX over 20 of.
How Much Did Matt Damon Get Paid For Thor: Ragnarok, Easyshop Shop Designer, Gavin Houston Cosby Show, John Vidalakis Nashville, Articles S